Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiko Watanabe

Showing results (181-190 of 217) with videos related to

Pageof 22
Sort By:
International Journal of Clinical Oncology|June 28, 2018
Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatmentsShota Omori, Hirotsugu Kenmotsu, Masato Abe, et al.
Nature Structural & Molecular Biology|November 13, 2012
Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1Catherine A Musselman, Nikita Avvakumov, Reiko Watanabe, et al.
Cancer Science|November 12, 2022
Clinicopathological features and prognostic impact of dirty necrosis in metastatic lung cancers from the colon and rectumYasuhito Konishi, Tetsuro Taki, Tokiko Nakai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stageMiguel A Morales, Reiko Watanabe, Mariko Dacher, et al.
Proteomics|October 21, 2010
Identification of Leishmania-specific protein phosphorylation sites by LC-ESI-MS/MS and comparative genomics analysesSonia Hem, Pier Federico Gherardini, José Osorio y Fortéa, et al.
International Journal of Clinical Oncology|December 20, 2012
Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimensTakaaki Tokito, Hirotsugu Kenmotsu, Reiko Watanabe, et al.
Hematological Oncology|December 9, 2015
The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDSShinichi Kako, Yoshinobu Kanda, Jun Kato, et al.
Plos One|June 13, 2024
Clinical and analytical validation of an 82-gene comprehensive genome-profiling panel for identifying and interpreting variants responsible for inherited retinal dystrophiesJacqueline Chan, Jolyon Holdstock, John Shovelton, et al.
The American Journal of Surgical Pathology|October 12, 2020
CNS Low-grade Diffusely Infiltrative Tumors With INI1 Deficiency, Possessing a High Propensity to Progress to Secondary INI1-deficient Rhabdoid TumorsSumihito Nobusawa, Satoshi Nakata, Yoshiko Nakano, et al.
Brain Tumor Pathology|November 26, 2021
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomasTomohide Nishikawa, Reiko Watanabe, Yotaro Kitano, et al.
Pageof 22

Showing results (181-190 of 217) with videos related to

Sort By:
Pageof 22
International Journal of Clinical Oncology|June 28, 2018
Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatmentsShota Omori, Hirotsugu Kenmotsu, Masato Abe, et al.
Nature Structural & Molecular Biology|November 13, 2012
Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1Catherine A Musselman, Nikita Avvakumov, Reiko Watanabe, et al.
Cancer Science|November 12, 2022
Clinicopathological features and prognostic impact of dirty necrosis in metastatic lung cancers from the colon and rectumYasuhito Konishi, Tetsuro Taki, Tokiko Nakai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stageMiguel A Morales, Reiko Watanabe, Mariko Dacher, et al.
Proteomics|October 21, 2010
Identification of Leishmania-specific protein phosphorylation sites by LC-ESI-MS/MS and comparative genomics analysesSonia Hem, Pier Federico Gherardini, José Osorio y Fortéa, et al.
International Journal of Clinical Oncology|December 20, 2012
Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimensTakaaki Tokito, Hirotsugu Kenmotsu, Reiko Watanabe, et al.
Hematological Oncology|December 9, 2015
The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDSShinichi Kako, Yoshinobu Kanda, Jun Kato, et al.
Plos One|June 13, 2024
Clinical and analytical validation of an 82-gene comprehensive genome-profiling panel for identifying and interpreting variants responsible for inherited retinal dystrophiesJacqueline Chan, Jolyon Holdstock, John Shovelton, et al.
The American Journal of Surgical Pathology|October 12, 2020
CNS Low-grade Diffusely Infiltrative Tumors With INI1 Deficiency, Possessing a High Propensity to Progress to Secondary INI1-deficient Rhabdoid TumorsSumihito Nobusawa, Satoshi Nakata, Yoshiko Nakano, et al.
Brain Tumor Pathology|November 26, 2021
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomasTomohide Nishikawa, Reiko Watanabe, Yotaro Kitano, et al.
Pageof 22